ACC.20/WCC Highlights Podcast Part 1 of 3

Order of abstracts:

1. Armstrong et al - VICTORIA trial - Vericiguat shows beneficial effects in very high-risk HF population
2. Bonaca et al - VOYAGER-PAD trial - Rivaroxaban and aspirin effective and safe for PAD patients
3. Pereira et al - TAILOR-PCI trial - TAILOR-PCI misses endpoint but still provides valuable insights
4. Leon et al - PARTNER 3 trial - 2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis
5. Agnelli et al - CARAVAGGIO trial - Apixaban offers new perspective for cancer patients in need of anticoagulation
6. Samama et al - Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Posted on 5 September, 202022 December, 2020